A human iPS cell line was generated from fibroblasts of a phenotypically unaffected patient from a family with PRPF31-associated retinitis pigmentosa (RP). The transgene-free iPS cells were generated with the human OSKM transcription factors using the Sendai-virus reprogramming system. iPS cells contained the expected c.709-734dup substitution in exon 8 of PRPF31, expressed the expected pluripotency markers, displayed in vivo differentiation potential to the three germ layers and had normal karyotype. This cellular model will provide a powerful tool to study the unusual pattern of inheritance of PRPF31-associated RP.
PRPF31-4138-iPS

Resource utility
This PRPF31-4138-iPS cell line constitutes a unique tool to study the pathogenesis of PRPF31-associated Retinitis Pigmentosa (RP). The feature of incomplete penetrance could be directly evaluated in cells affected by RP by the generation of photoreceptors and retinal pigmented epithelial cells carrying the PRPF31 mutation from this iPS cell line.
Resource details
Mutations in gene that encode pre-mRNA processing factor 31 (PRPF31) are one of the most common causes of the dominant form of Retinitis Pigmentosa (RP), a form of retinal degeneration that causes progressive visual impairment. Interestingly, mutations in ubiquitously expressed PRPF31 produce a retina-specific phenotype and are nonpenetrant, with some mutation carriers being normally sighted and asymptomatic in affected families (Rose and Bhattacharya, 2016) . In this study, skin fibroblasts from a 75-year-old asymptomatic carrier (Audo et al., 2010) were reprogrammed into iPS cells using nonintegrative Sendai viruses containing the reprogramming factors, OCT3/4, SOX2, CMYC, KLF4. The presence of the mutation (c.709-734dup) in the derived PRPF31-4138-iPS cell line was confirmed by Sanger sequencing (Fig. 1A) . iPS cell colonies displayed a typical ES cell-like colony morphology and growth behavior and they stained positive for alkaline phosphatase activity (Fig. 1B) . We confirmed that PRPF31-4138-iPS cells were free from mycoplasma contamination (Fig. 1C ) and the clearance of the vectors and the exogenous reprogramming factor genes by qPCR after ten passages ( Supplementary Fig. 1A ). PRPF31-4138-iPS cells exhibited typical markers of pluripotency with expression of DNMT3B, LIN28A, NANOG, NODAL, POU5F1 (OCT4), TERT and GDF3 evaluated by RT-qPCR ( Fig. 1D) , of NANOG and TRA1-60 evaluated by immunohistochemical staining (Fig. 1E ) and of SSEA-4 and TRA1-81 assessed by flow cytometry (Fig. 1F) . The PRPF31-4138-iPS cell line displayed a normal karyotype (46, XY) after more than twenty culture passages (Fig. 1G) . Single nucleotide polymorphism (SNP) genotyping of original fibroblasts and the generated PRPF31-4138-iPS cell line validated the identity and genomic integrity of the iPS cell line (Supplementary Fig. 1B ). Teratoma assays showed the presence of normal differentiation towards endodermal, ectodermal and mesodermal layers (Fig. 1H ). Taken together, we have successfully reprogrammed p.Cys247X PRPF31 dermal fibroblasts into iPS cells that can be used to generate retinal cells (Reichman et al., , 2014 in order to study pathogenic mechanism underlying RP caused by mutation in PRPF31 and the nonpenetrance of the disease phenotype in affected families (Tables 1 and  2 ).
Materials and methods
Human fibroblast cultures and reprogramming
Human fibroblasts were cultured and reprogrammed using the CytoTune Sendai reprogramming vectors Oct4, Klf4, Sox2 and c-Myc (Thermo Fisher Scientific) as previously reported . The emergent iPS cell colonies were picked under a stereomicroscope and expanded on mitomycined human foreskin feeder layers. After generation of a frozen stocks, iPS cells were preferentially adapted and cultured in feeder free conditions . Absence of mycoplasma contamination was verified by the MycoAlert™ Mycoplasma Detection Kit (selective biochemical test of mycoplasma enzymes) according to the manufacturer's instructions (Lonza). After ten passages, the clearance of the exogenous reprogramming factors and Sendai virus genome was confirmed by qPCR following the manufacturer's instructions (Thermo Fisher Scientific).
Mutation analysis
Genomic DNA from human iPS cells was extracted with Nucleospin Tissue Kit (Macherey-Nagel) according to the manufacturer instruction. PCR amplification flanking exon 8 of PRPF31 (Table S2 ) was performed using HOT FIRE Pol DNA Polymerase (Solis BioDyne). PCR products were sequenced using BigDye® Terminator v1.1 Cycle Sequencing Kit (Thermo Fisher Scientific) on a 3730 DNA analyzer (Applied Biosystems).
Karyotype analyses
Conventional cytogenetic analysis was performed as described previously (Reichman et al., 2014) . Molecular karyotype was analyzed by SNP genotyping using Illumina's Infinium HumanCore-24 Bead Chips (Illumina, Inc., San Diego, USA) at Integragen (Evry, France). Processing was performed on genomic DNA following the manufacturer's procedures. LogR ratio and B allele plots were generated in GenomeStudio software (Illumina, Inc.).
In vivo pluripotency analysis by teratoma formation assay
Teratoma assays were performed as described previously (Reichman et al., 2014) .
Real-time PCR analysis
Total RNAs were extracted using Nucleospin RNA II kit (MachereyNagel) and cDNA synthesized using the QuantiTect reverse transcription kit (Qiagen) following manufacturer's recommendations. qPCR analysis was performed in three minimum independent biological experiments with custom TaqMan® Array 96-Well Fast plates (Thermo Fisher Scientific) according to the manufacturer's protocol as described previously (Reichman et al., 2014) .
Flow cytometry
Cells were detached with Accutase solution and harvested for quantitative analysis by flow cytometry (Cytomics FC500 MCL; Beckman Coulter) by staining the TRA-1-81, and SSEA-4 antibodies and data were analyzed with FlowJo software.
Alkaline phosphatase and immunofluorescence staining
Staining of fixed hiPS cells was performed as described previously (Reichman et al., 2014) .
Supplementary data to this article can be found online at https://doi. org/10.1016/j.scr.2017.10.007. 
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